In several cancer screening trials including CRC, genotyping was performed for 679 patients with advanced distal adenomas and controls on two HFE mutations (C282Y and H63D), HFE polymorphism (IVS2 + 4) and the transferrin receptor gene polymorphism (G142S). Here, TFRC is linked to colorectal carcinoma.